Pliant Therapeutics Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pliant therapeutics daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pliant Therapeutics Daily Today - Breaking & Trending Today

Rhenman & Partners Asset Management AB Has $2.04 Million Holdings in Pliant Therapeutics, Inc. (NASDAQ:PLRX)

Rhenman & Partners Asset Management AB decreased its position in Pliant Therapeutics, Inc. (NASDAQ:PLRX – Free Report) by 65.9% during the 4th quarter, Holdings Channel.com reports. The firm owned 112,741 shares of the company’s stock after selling 217,894 shares during the period. Rhenman & Partners Asset Management AB’s holdings in Pliant Therapeutics were worth $2,042,000 […] ....

United States , Exchange Commission , Needham Company , Silverarc Capital Management , Vanguard Group Inc , Pliant Therapeutics Inc , Royal Bank , Barclays Plc , Holdings Channel , Pliant Therapeutics Company Profile , Franklin Resources Inc , Partners Asset Management , Pliant Therapeutics , Free Report , Capital Management , Franklin Resources , Get Free Report , Visit Holdingschannel , Pliant Therapeutics Daily ,

Rhenman & Partners Asset Management AB Sells 217,894 Shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX)

Rhenman & Partners Asset Management AB cut its holdings in Pliant Therapeutics, Inc. (NASDAQ:PLRX – Free Report) by 65.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 112,741 shares of the company’s stock after selling 217,894 shares during the period. Rhenman […] ....

United States , New York , Charles Schwab Investment Management Inc , Royal Bank , Quest Partners , Exchange Commission , China Universal Asset Management Co , York State Common Retirement Fund , Pliant Therapeutics Inc , Needham Company , Partners Asset Management , Pliant Therapeutics , Free Report , State Retirement System , Universal Asset Management , Charles Schwab Investment Management , Schwab Investment Management , Get Free Report , Pliant Therapeutics Daily ,

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Given Consensus Recommendation of "Buy" by Analysts

Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Free Report) has received a consensus recommendation of “Buy” from the nine ratings firms that are currently covering the firm, MarketBeat.com reports. Nine investment analysts have rated the stock with a buy recommendation. The average 1-year target price among brokerages that have issued a report on the stock in […] ....

United States , Rathbones Group , China Universal Asset Management Co , Needham Company , Corton Capital Inc , Quest Partners , Pliant Therapeutics Company Profile , Royal Bank , Pliant Therapeutics Inc , Sg Americas Securities , Pliant Therapeutics , Get Free Report , Universal Asset Management , Get Free , Pliant Therapeutics Daily ,

Pliant Therapeutics (NASDAQ:PLRX) Receives Buy Rating from HC Wainwright

HC Wainwright restated their buy rating on shares of Pliant Therapeutics (NASDAQ:PLRX – Free Report) in a research report sent to investors on Wednesday morning, Benzinga reports. The firm currently has a $36.00 target price on the stock. A number of other equities analysts also recently weighed in on the stock. Oppenheimer boosted their price […] ....

United States , British Columbia , Entrypoint Capital , Vanguard Group Inc , Pricet Rowe Associates Inc , Capital International Investors , Needham Company , Royal Bank , Redmile Group , Pliant Therapeutics Inc , Pliant Therapeutics , Free Report , Therapeutics Stock Down , Get Free Report , International Investors , Point Capital , Vanguard Group , Pliant Therapeutics Daily ,

Pliant Therapeutics (NASDAQ:PLRX) Given "Buy" Rating at HC Wainwright

HC Wainwright restated their buy rating on shares of Pliant Therapeutics (NASDAQ:PLRX – Free Report) in a research note published on Wednesday morning, Benzinga reports. HC Wainwright currently has a $36.00 target price on the stock. Other equities research analysts also recently issued research reports about the company. Royal Bank of Canada cut their price […] ....

New York , United States , York State Common Retirement Fund , China Universal Asset Management Co , Barclays Plc , York Mellon Corp , Needham Company , Td Asset Management Inc , Pliant Therapeutics Inc , Royal Bank , Pliant Therapeutics , Free Report , Get Free Report , New York Mellon Corp , Management Inc , Universal Asset Management , New York State Common Retirement Fund , Pliant Therapeutics Daily ,